157 related articles for article (PubMed ID: 35261285)
1. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 May; 11(7):473-475. PubMed ID: 35261285
[TBL] [Abstract][Full Text] [Related]
2. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2024 Jan; 13(1):e230189. PubMed ID: 38179957
[TBL] [Abstract][Full Text] [Related]
3. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2023 Jan; 12(1):e220194. PubMed ID: 36453665
[TBL] [Abstract][Full Text] [Related]
4. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 7.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jul; 11(10):699-701. PubMed ID: 35506497
[TBL] [Abstract][Full Text] [Related]
5. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jan; 11(1):11-12. PubMed ID: 34702048
[TBL] [Abstract][Full Text] [Related]
6. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Mar; 11(4):213-215. PubMed ID: 34989244
[TBL] [Abstract][Full Text] [Related]
7. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Sep; 11(13):915-917. PubMed ID: 35703134
[TBL] [Abstract][Full Text] [Related]
8. R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Sep; 10(13):957-959. PubMed ID: 34184540
[TBL] [Abstract][Full Text] [Related]
9. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Nov; 11(16):1147-1149. PubMed ID: 35998008
[TBL] [Abstract][Full Text] [Related]
10. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2023 Nov; 12(11):e230141. PubMed ID: 37712636
[TBL] [Abstract][Full Text] [Related]
11. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 3.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Nov; 10(16):1175-1176. PubMed ID: 34412538
[TBL] [Abstract][Full Text] [Related]
12. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Jul; 10(10):797-799. PubMed ID: 33955236
[TBL] [Abstract][Full Text] [Related]
13. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.
Castanon A; Bray BD; Ramagopalan SV
J Comp Eff Res; 2024 May; 13(5):e240033. PubMed ID: 38546012
[TBL] [Abstract][Full Text] [Related]
14. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11.
Bray B; Ramagopalan SV
J Comp Eff Res; 2023 May; 12(5):e230008. PubMed ID: 37052075
[TBL] [Abstract][Full Text] [Related]
15. Access in all areas? A round up of developments in market access and health technology assessment: part 1.
Gilardino R; Treharne C; Mardiguian S; Ramagopalan SV
J Comp Eff Res; 2023 Oct; 12(10):e230129. PubMed ID: 37584405
[TBL] [Abstract][Full Text] [Related]
16. Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Dai WF; Craig E; Fraser B; Chambers A; Mai H; Brown MB; Earle CC; Evans WK; Geirnaert M; Taylor M; Trudeau M; Sperber D; Beca JM; Denburg A; Mercer RE; Parmar A; Tadrous M; Takhar P; Chan KKW; On Behalf Of The CanREValue Collaboration
Curr Oncol; 2021 Nov; 28(6):4645-4654. PubMed ID: 34898572
[TBL] [Abstract][Full Text] [Related]
17. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
[TBL] [Abstract][Full Text] [Related]
18. Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.
Dai WF; Arciero V; Craig E; Fraser B; Arias J; Boehm D; Bosnic N; Caetano P; Chambers C; Jones B; Lungu E; Mitera G; Potashnik T; Reiman A; Ritcher T; Beca JM; Denburg A; Mercer RE; Parmar A; Tadrous M; Takhar P; Chan KKW; On Behalf Of The CanREValue Collaboration Reassessment And Uptake Working Group
Curr Oncol; 2021 Oct; 28(5):4174-4183. PubMed ID: 34677272
[TBL] [Abstract][Full Text] [Related]
19. Real-world evidence in lung and hematologic oncology health technology appraisals: a review of six assessment agencies.
Harricharan S; Curran E; Lin HM; Walton L; Gurjar K; Nguyen K; Forsythe A
Future Oncol; 2023 Mar; 19(8):603-616. PubMed ID: 37083358
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on current status of health technology reassessment: insights for South Korea.
Seo HJ; Park JJ; Lee SH
Health Res Policy Syst; 2016 Nov; 14(1):82. PubMed ID: 27835964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
